Practical Considerations to Manage Residual ASCVD Risk

Published: June 16, 2020, 4 a.m.

Host: Sergio Fazio, MD, PhD

The therapeutic landscape for ASCVD is evolving rapidly. Stay ahead of the clinical curve with this video presentation with slides, featuring renowned cardiovascular expert Dr. Sergio Fazio, Professor of Medicine and Director of the Center for Preventive Cardiology at Oregon Health & Science University. Dr. Fazio highlights a recent ACP symposium and shares practical considerations on the latest guidelines for risk stratification and new guideline-recommended approaches to the management of atherosclerotic cardiovascular disease (ASCVD) risk reduction beyond statin therapy.